AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 285: H2284-H2289, 2003. First published July 10, 2003; doi:10.1152/ajpheart.00459.2003
0363-6135/03 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/H2284    most recent
00459.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamseddine, A. H.
Right arrow Articles by Miller, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamseddine, A. H.
Right arrow Articles by Miller, F. J., Jr.

CALL FOR PAPERS

gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells

Ali H. Chamseddine and Francis J. Miller, Jr.

Departments of Internal Medicine and Free Radical and Radiation Biology Program, University of Iowa, Iowa City, Iowa 52242

Submitted 20 May 2003 ; accepted in final form 8 July 2003


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Reactive oxygen species (ROS) derived from vascular NADPH oxidase are important in normal and pathological regulation of vessel growth and function. Cell-specific differences in expression and function of the catalytic subunit of NADPH oxidase may contribute to differences in vascular cell response to NADPH oxidase activation. We examined the functional expression of gp91phox on NADPH oxidase activity in vascular smooth muscle cells (SMC) and fibroblasts (FB). As measured by dihydroethidium fluorescence in situ, superoxide levels were greater in adventitial cells compared with medial SMC in wild-type aorta. In contrast, there was no difference in levels between adventitial cells and medial SMC in aorta from gp91phox-deficient (gp91phox KO) mice. Adventitial-derived FB and medial SMC were isolated from the aorta of wild-type and gp91phox KO mice and grown in culture. Consistent with the observations in situ, basal and stimulated ROS levels were reduced in FB isolated from aorta of gp91phox KO compared with FB from wild-type aorta, whereas ROS levels were similar in SMC derived from gp91phox KO and wild-type aorta. There were no differences in expression of superoxide dismutase between gp91phox KO and wild-type FB to account for these observations. Because gp91phox is associated with membranes, we examined NADPH-stimulated production in membrane-enriched fractions of cell lysate. As measured by chemiluminescence, NADPH oxidase activity was markedly greater in wild-type FB compared with gp91phox KO FB but did not differ among the SMCs. Confirming functional expression of gp91phox in FB, antisense to gp91phox decreased ROS levels in wild-type FB. Finally, deficiency of gp91phox did not alter expression of the gp91phox homolog NOX4 in isolated FB. We conclude that the neutrophil subunit gp91phox contributes to NADPH oxidase function in vascular FB, but not SMC.

reactive oxygen species; blood vessel


ALTHOUGH SMOOTH MUSCLE CELLS (SMC) have long been recognized to contribute to vascular function and remodeling, there is increasing evidence that adventitial fibroblasts (FB) may have a similar role in the blood vessel (8, 14). Not only can FB modulate endothelial responses via paracrine mechanisms (13), they may also migrate to the intima after vascular injury and contribute to neointimal formation (16, 17).

Many of the effects of vascular cells appear to be mediated, in part, by cellular-derived reactive oxygen species (ROS). ROS have multiple effects in blood vessels. In addition to the well-described inactivation of nitric oxide and oxidation of lipoproteins, ROS participate in intracellular signaling and regulation of gene expression (7, 12). In this way, vascular cell-derived ROS may regulate vessel growth and function in atherosclerosis, hypertension, and diabetes mellitus (3, 6).

Although there are several potential sources of ROS in the blood vessel, a phagocyte-like NADPH oxidase is thought to be the major source of (6). In phagocytes, NADPH oxidase generates through the assembly of a multisubunit protein complex composed of the membrane-associated flavin and heme containing gp91phox and the smaller p22phox. Cytosolic components p47phox and p67phox are involved in activation of the oxidase after stimulation of the cell (2). It has recently been suggested that the phagocyte gp91phox subunit is not involved in vascular cell NADPH oxidase activity (19). However, this study failed to examine individual cell types within the vessel wall. Gorlach et al. (5) have shown that gp91phox is expressed and contributes to production and intracellular signaling in endothelial cells. Expression of gp91phox protein has been reported in arteriolar SMC (20) but is not found in aortic SMC (6). The role of gp91phox in FB is less well defined; however, gp91phox is expressed in adventitial cells and appears to contribute to generation of adventitial (11, 13).

Complicating the characterization of the vascular NADPH oxidase is the finding that homologs of gp91phox are expressed in vascular cells and may contribute to NADPH oxidase-derived ROS (6). The effect of gp91phox deficiency on NADPH oxidase activity in isolated FB and SMC has not been studied. We hypothesized that deficiency of gp91phox would reduce NADPH oxidase activity in isolated FB but not aortic SMC. We also examined whether expression of NOX4, the most abundant gp91phox homolog in vascular cells, is altered by deficiency of gp91phox.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Tissue culture. Adventitial FB and medial SMC were cultured from the thoracic aorta of wild-type and gp91phox-deficient (gp91phox KO) mice (Jackson Laboratory; Bar Harbor, ME). The loosely adhering perivascular tissue was trimmed from the aorta, and the endothelium was removed by scraping. Adhering adventitial cells were microdissected from the vessel. The adventitial layer and the medial layer were subjected to enzymatic digestion and culture as described (9). Three independent isolations of gp91phox KO SMC and FB and three parallel isolations of wild-type control SMC and FB were obtained. Cells were grown in 10% fetal calf serum in DMEM containing 1% basal medium Eagle, 1% glutamine, 1% penicillin-streptomycin, 1% MEM 100x nonessential amino acids, and 2% HEPES. FB were confirmed by negative {alpha}-actin staining and SMCs by positive {alpha}-actin staining at second passage. Studies were performed at passages 4 to 9 and 70–90% confluence. All experimental protocols were approved by the University of Iowa Animal Care and Use Committee and conform to American Physiological Society guidelines for the use and care of laboratory animals.

Fluorescent dyes for detection of ROS. Immediately after harvest, aortic segments were rinsed in cold PBS and flash frozen in OCT mounting compound (Sakura). Perivascular tissue was not dissected away from the vessel so as to minimize trauma to the adventitial cells before measuring ROS levels. Aortas were sectioned (30 µm) and incubated in 5- and 6-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (DCFH; 2 x 10–6 M) or dihydroethidium (DHE; 2 x 10–6 M) for 30 min at 37°C as previously described (13). Cultured SMC and FB were grown on chamber slides, serum-deprived (0.1% serum) overnight, washed with PBS, and incubated with DCHF or DHE for 30 min at 37°C. Cells were rinsed with PBS and coverslipped. Fluorescence was detected with a Bio-Rad laser scanning confocal microscope (excitation at 488 nm and detection at 585 nm by using a long-pass filter). Control wild-type and gp91phox KO vessels or cells were analyzed in parallel under identical laser settings. Relative superoxide levels within vessel segments were quantitated by determining relative fluorescence per cell in the adventitia and media by using Scion Image (version 4.0).

In other experiments, SMC and FB were grown in 35-mm dishes, washed in PBS, and incubated in DCFH or DHE for 30 min in the dark at 37°C. Cells were washed with PBS, detached with trypsin, and collected by centrifugation. Fluorescence was measured by a Becton Dickinson (Franklin Lakes, NJ) FACScan, and data were analyzed with WinMDI flow cytometry software. These data are reported as relative fluorescent units per cell normalized to control cells. In some experiments, NADPH oxidase was activated by the addition of phorbol 12,13-dibutyrate (10–6 M) 15 min after the addition of the fluorescent dye.

Chemiluminescence. SMC and FB were grown on 35-mm dishes, serum deprived overnight, and rinsed in PBS, and basal was measured by lucigenin (5 x 10–6 M)- or coelenterazine (10–5 M)-enhanced chemiluminescence in a luminometer (model FB12; Zylux) after 10 min of dark adaptation. In other experiments, cells were detached by trypsin, collected by centrifugation, and rinsed in PBS. Cells were suspended in ice-cold protease inhibitor buffer and sonicated on ice. The homogenate was centrifuged at 500 g for 10 min, the supernatant centrifuged at 30,000 g for 30 min, and then the supernatant centrifuged at 75,000 g for 1 h at 4°C. The pellet was suspended in protease inhibitor buffer and protein content was determined. NADPH oxidase activity of 20 µg protein was measured as the diphenyleneiodonium (DPI; 10–4 M)-inhibited lucigenin (5 x 10–6 M)- or methyl-cypridina-luciferin analog (MCLA; 10–6 M)-enhanced chemiluminescence after the addition of NADPH (10–4 M) (10). Chemiluminescence data are reported as relative light units per second normalized to cell number or protein concentration.

Western blot analysis. Cells were rinsed with PBS, harvested in SDS lysis buffer, and boiled for 5 min. Proteins were separated by using 4–20% Tris · HCl ready gel and transferred onto nitrocellulose membrane. The membrane was probed with mouse monoclonal anti-gp91phox (1:1,000), sheep polyclonal anti-CuZn-SOD (1:1,000), or rabbit polyclonal anti-Mn-SOD antibodies (1:1,000) at 4°C overnight. Secondary anti-mouse, anti-sheep, or anti-rabbit antibodies (1:10,000) were added at room temperature for 1 h and detected after the addition of SuperSignal West Pico chemiluminescent substrate using Kodak film.

gp91phox Antisense. Cells were grown to 40–50% confluence and treated with the single-stranded antisense oligonucleotide (ODN) mixed with Oligofectamine (Invitrogen; Carlsbad, CA) as per the manufacturer's instructions. Expression of gp91phox and levels were measured after 24 h. The gp91phox antisense ODN had the sequence 5'-AACTGGGCTGTGAATGAAG-3', and the scrambled control ODN had the sequence 5'-CATTGTGGAGTGACAGGAG-3'. The antisense targeted base pairs 7–25 of the coding sequence of gp91phox mRNA (21).

NOX4 RT-PCR. Real-time PCR was used to measure mRNA expression of the gp91phox homolog NOX4. Total mRNA was isolated from cultured SMC and FB by using Tri-Reagent (Molecular Research Center; Cincinnati, OH). Relative copy number of NOX4 was determined by using the QuantiTect SYBRgreen PCR kit (Qiagen; Valencia, CA) and ABI Prism 7000 (Applied Biosystems; Foster City, CA) detection system normalized to ribosomal 18S RNA. The primer pairs for NOX4 were sense 5'-CTGGTCTGACGGGTGTCTGCATGGTG-3' and antisense 5'-CTCCGCACAATAAAGGCACAAAGGTCCAG-3' (GenBank accession no. AB 041034).

Chemicals. Anti-gp91phox (monoclonal antibody 54.1) was obtained by permission from Dr. A. J. Jesaitis, Department of Microbiology, Montana State University. Anti-CuZn-SOD was obtained from Calbiochem (San Diego, CA). Anti-Mn-SOD was a gift from Dr. Larry Oberley, University of Iowa. Anti-mouse, anti-sheep, and anti-rabbit secondary antibodies were obtained from Upstate Biotechnology (Waltham, MA). Coelenterazine, DCFH, and DHE were obtained from Molecular Probes (Eugene, OR). All other chemicals, unless indicated, were obtained from Sigma-Aldrich (St. Louis, MO).

Statistical analysis. Results are expressed as means ± SE. Statistical comparisons were performed by Student's two-tailed t-tests or ANOVA as appropriate. A value of P < 0.05 was considered significant.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
Superoxide levels, as measured by DHE fluorescence, were greater in adventitial cells compared with medial SMC in wild-type aorta (Fig. 1). In contrast, levels were similar in the adventitial cells and medial SMC in gp91phox KO aorta. This difference in relative levels between adventitial and medial cells resulted from increased in adventitial cells of wild-type aorta compared with cells within the adventitia of gp91phox KO aorta. These observations suggest that gp91phox contributes to the generation of in adventitial FB but not SMC.



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1. Basal levels in aorta from wild-type (wt) and gp91phox-deficient (gp91phox KO) mice. Aortic sections were incubated with dihydroethidium (DHE), and fluorescent images were obtained by confocal microscopy. Arrow indicates endothelium. Right, summary data of the ratio of adventitial cell to medial smooth muscle cells (SMC) fluorescence after DHE staining. Open symbols, data from individual aorta; closed symbols, means ± SE. RFU, relative fluorescent units (n = 7–9 aorta sections; P < 0.05).

 

To better evaluate the functional role of gp91phox in NAPDH oxidase activity in vascular cells, we isolated SMC and FB from the aorta of wild-type and gp91phox KO mice. Under quiescent conditions, levels were greater in FB compared with SMC cultured from wild-type aorta (Fig. 2A). In contrast, levels were similar in SMC and FB isolated from gp91phox KO aorta. These observations were confirmed by measurement of by coelenterazine chemiluminescence (data not shown). Western blotting confirmed the absence of gp91phox in FB cultured from the gp91phox KO aorta (Fig. 2B).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 2. A: basal production in cultured cells. Fibroblasts (FB) and SMC were cultured from wt and gp91phox KO aorta. was measured by lucigenin-enhanced chemiluminescence and is reported as relative light units (RLU) · min–1 · 104 cells–1 (n = 6–8, *P < 0.05 vs. SMC). B: expression of gp91phox. Western blotting for gp91phox in spleen and FB from wt and gp91phox KO aorta is shown.

 

Intracellular levels of ROS were further characterized in FB with the fluorescent dyes DHE and DCFH. Superoxide (Fig. 3, A and C) and peroxide-derived (Fig. 3, B and C) radicals were greater in FB from wild-type aorta compared with FB from gp91phox KO aorta. Differences in ROS levels between wild-type and gp91phox KO FB were not due to differences in expression of intracellular superoxide dismutase (Fig. 3D).



View larger version (35K):
[in this window]
[in a new window]
 
Fig. 3. Reactive oxygen species (ROS) levels in cultured FB. A: basal intracellular levels of FB measured by DHE fluorescence using confocal microscopy. B: basal peroxide-derived radicals in FB measured by dichlorodihydrofluorescein (DCFH) fluorescence (RFU/cell) using flow cytometry. C: summary data of basal ROS levels in gp91phox KO FB measured by DCFH (solid bar) and DHE (crosshatched bar) by using flow cytometry. ROS levels are reported as RFU per cell normalized to wt (open bar) (n = 13 aorta sections, *P < 0.05 vs. wt). D: Western blotting for CuZn-SOD and Mn-SOD in wt- and gp91phox KO-cultured FB is shown. Data are representative of 3 separate experiments.

 

Activation of NADPH oxidase by phorbol ester increased intracellular ROS levels in wild-type-derived aortic FB, but not FB from gp91phox KO aorta (Fig. 4A). In comparison, the mitochondrial electron chain uncoupler menadione increased levels similarly in wild-type and gp91phox KO FB (2.0 ± 0.2 vs. 1.9 ± 0.3-fold normalized to untreated FB, n = 3).



View larger version (9K):
[in this window]
[in a new window]
 
Fig. 4. NADPH oxidase activity. A: cultured FB were stimulated with phorbol 12,13-dibutyrate (PDB; solid bars), and ROS levels were measured by DCFH fluorescence and flow cytometry. ROS levels are reported as RFU per cell normalized to untreated FB (open bars) (n = 4 aorta, *P < 0.05 vs. untreated). B: membrane-enriched fractions of cells cultured from wt (open bars) and gp91phox KO (filled bars) aorta were treated with NADPH (0.1 mM) and measured by lucigenin-enhanced chemiluminescence (n = 5 aorta sections, *P < 0.05 vs. wt FB).

 

Because gp91phox is a membrane-associated subunit of NADPH oxidase, SMC and FB membrane-enriched fractions were treated with NADPH and measured by lucigenin-enhanced chemiluminescence (Fig. 4B). NADPH-stimulated production was similar in SMC isolated from both wild-type and gp91phox KO aorta. In contrast, NADPH-stimulated was markedly reduced in membrane fractions of gp91phox KO FB compared with wild-type FB. This finding of decreased NADPH oxidase activity in FB of gp91phox KO aorta was confirmed by MCLA chemiluminescence (277 ± 2.1 vs. 210 ± 2.1 RLU · min–1 · mg protein–1, n = 3). The flavoenzyme inhibitor DPI reduced NADPH-stimulated generation by >70%.

Further confirming that gp91phox contributes to NADPH oxidase activation and generation of in FB, wild-type FB were found to have decreased levels of after treatment with antisense to gp91phox (Fig. 5). Western blotting verified reduction in gp91phox protein levels in murine monocytes after antisense treatment (Fig. 5).



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 5. Effect of gp91phox antisense. A: Western blotting of cultured murine monocytes after treatment with vehicle (veh) or gp91phox antisense (1.0 and 1.5 µM). B: levels as measured by DHE fluorescence using confocal microscopy in FB cultured from wt and gp91phox KO aorta after treatment with veh or gp91phox antisense (1.0 and 1.5 µM). Data are representative of 3 separate experiments.

 

NOX4 is a homolog of gp91phox and is presumed to serve as a catalytic subunit for NADPH oxidase (6). Real-time PCR confirmed expression of NOX4 in wild-type SMC and FB (SMC, 1.5 ± 0. 4 and FB, 2.6 ± 0.8 NOX4/103 copies 18S, n = 3). NOX4 levels in gp91phox KO FB (2.3 ± 0.8 NOX4/103 copies 18S, n = 3) were not different than NOX4 levels in wild-type FB.


    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
In this study, we clearly document the importance of gp91phox in NADPH oxidase-derived in vascular FB and the functional absence of gp91phox in vascular SMC. Our findings indicate that expression of the gp91phox homolog NOX4 in FB is not altered by deficiency of gp91phox. We also demonstrate that intracellular levels of are greater in adventitial FB compared with SMC, and that gp91phox contributes <30% of ROS levels in the quiescent FB.

A major source of ROS in vascular cells is a phagocyte-type NADPH oxidase. Activation of a vascular NADPH oxidase has been associated with vascular dysfunction in disease (3, 6). The structure of NADPH oxidase is well characterized in neutrophils, consisting of a membrane-associated cytochrome b558 composed of a p22phox-gp91phox heterodimer, and the cytosolic subunits p47phox, p40phox, p67phox, and Rac (2). On activation, the cytosolic subunits bind to the membrane-bound complex to form a functional oxidase. In the blood vessel, expression of the specific NADPH oxidase subunits is dependent on cell type and vessel size. gp91phox, p22phox, p47phox, and p67phox are expressed in endothelial cells and FBs, whereas gp91phox and p67phox are not found in SMC of aorta (6). Interestingly, gp91phox and p67phox are expressed in SMC isolated from resistance arteries (20).

Consistent with previous reports, we were able to detect a small amount of gp91phox mRNA by RT-PCR (data not shown) but unable to detect gp91phox protein in SMC derived from aorta (18). In contrast to SMC and consistent with previous reports (11), gp91phox protein was expressed in vascular FB. For the first time, our data show functional evidence of gp91phox-dependent generation of in isolated FB. In addition, we confirm that gp91phox does not contribute to NADPH oxidase-derived production in aortic SMC. These observations provide further evidence that the structure of NADPH oxidase differs among vascular cell types.

Despite the functional absence of gp91phox, SMC demonstrate NADPH oxidase activity. This is evident by an increase in SMC ROS after stimulation with a phorbol ester and by NADPH oxidase-derived in membrane-enriched SMC homogenates. The observation that NADPH-stimulated is DPI inhibitable suggests that a -generating flavoenzyme is responsible for ROS production in SMC. Recently, a family of gp91phox homologs, referred to as NOX, have been shown to be present in vascular cells (6). The most prevalent NOX isoform in SMC and FB is NOX4 (18). If the expression of NOX4 is dependent on gp91phox, then NOX4 expression might be altered in FB deficient in gp91phox. For example, NOX4 levels may be expected to undergo a compensatory increase in response to a decrease in gp91phox. However, we found no difference in NOX4 levels between wild-type and gp91phox KO FB. The homolog NOX1 could also potentially contribute to NADPH oxidase activity in SMC and FB, but we were unable to detect NOX1 in these cells.

Our data suggest that under quiescent culture conditions, gp91phox contributes to <30% of superoxide generation in FBs (Figs. 2A and 3C). Other cellular sources, including gp91phox homologs, mitochondria, cytochrome P-450, and arachidonate metabolism, would be expected to contribute to the remaining ROS generation. In contrast, gp91phox contributed to the majority of NADPH oxidase activity in FBs (Fig. 4B). Homologs of gp91phox may also contribute to NADPH oxidase activity, supported by our demonstration of NOX4 in FBs.

It has recently been suggested that the gp91phox of blood vessels is distinct from that found in the phagocyte (19). However, this conclusion was derived from studies in vessel segments after removal of periadventitial tissue and may be limited in that the predominant cell type in this preparation would be the SMC, which we confirm in the present study does not contain gp91phox. Our data, together with the findings of others (5, 22), confirm that the neutrophil gp91phox subunit does contribute to ROS generation in vascular FB and endothelium.

In the isolated blood vessel, generation of by adventitial cells modulates nitric oxide-mediated responses (4). Angiotensin II activation of a gp91phox-based NADPH oxidase in the adventitia impairs endothelium-dependent relaxation (13). In the isolated vessel segment, we cannot confirm that the FB and not other perivascular cells, including inflammatory cells or microvascular pericytes, are primarily responsible for generation of ROS. However, our findings in culture suggest that FB contribute to the reported adventitialderived in the blood vessel.

Adventitial FB may have an important role in the pathophysiology of vascular disease (8, 14). After balloon injury, there is migration of adventitial FB to the neointima (16, 17). Endoluminal injury activates adventitial FB, resulting in an NADPH oxidase-dependent increase in ROS (15). NADPH oxidase expression is also increased in adventitial FB in atherosclerosis (1). We demonstrate the functional importance of gp91phox in vascular FB and propose that activation of a gp91phox-based NADPH oxidase may contribute to the vessels response to injury. Differences in the expression of NADPH oxidase subunits may be important in defining vascular cell response to activation.


    DISCLOSURES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 
The project described was supported by National Heart, Lung, and Blood Institute Grants HL-03669 and HL-62984 (to F. J. Miller). Study contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.


    ACKNOWLEDGMENTS
 
The authors appreciate the expert assistance of the University of Iowa Roy J. and Lucille A. Carver College of Medicine Flow Cytometry Facility, Central Microscopy Research Facility, and DNA Facility.


    FOOTNOTES
 

Address for reprint requests and other correspondence: F. J. Miller, Jr., 200 Hawkins Rd., Rm. E315 GH, Dept. of Internal Medicine, Univ. of Iowa Hospital, Iowa City, IA 52242 (E-mail: francis-miller{at}uiowa.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 DISCLOSURES
 REFERENCES
 

  1. Azumi H, Inoue N, Takeshita S, Rikitake Y, Kawashima S, Hayashi Y, Itoh H, and Yokoyama M. Expression of NADH/NADPH oxidase p22phox in human coronary arteries. Circulation 100: 1494–1498, 1999.[Abstract/Free Full Text]
  2. Babior BM. NADPH oxidase: an update. Blood 93: 1464–1476, 1999.[Free Full Text]
  3. Cai H and Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840–844, 2000.[Abstract/Free Full Text]
  4. Diwang H, Pagano PJ, Du Y, Quinn MT, Brecher P, and Cohen RA. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82: 810–818, 1998.[Abstract/Free Full Text]
  5. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26–32, 2000.[Abstract/Free Full Text]
  6. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494–501, 2000.[Abstract/Free Full Text]
  7. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21–27, 2000.[ISI][Medline]
  8. Gutterman DD. Adventitia-dependent influences on vascular function. Am J Physiol Heart Circ Physiol 277: H1265–H1272, 1999.[Free Full Text]
  9. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298–1305, 1998.[Abstract/Free Full Text]
  10. Miller FJ Jr and Griendling KK. Functional evaluation of nonphagocytic NAD(P)H oxidases. Methods Enzymol 353: 220–233, 2002.[ISI][Medline]
  11. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, and Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci USA 94: 14483–14488, 1997.[Abstract/Free Full Text]
  12. Rao GN and Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 70: 593–599, 1992.[Abstract/Free Full Text]
  13. Rey FE, Li XC, Carretero OA, Garvin JL, and Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91phox. Circulation 106: 2497–2502, 2002.[Abstract/Free Full Text]
  14. Rey FE and Pagano PJ. The reactive adventitia: fibroblast oxidase in vascular function. Arterioscler Thromb Vasc Biol 22: 1962–1971, 2002.[Abstract/Free Full Text]
  15. Shi Y, Niculescu R, Wang D, Patel S, Davenpeck KL, and Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler Thromb Vasc Biol 21: 739–745, 2001.[Abstract/Free Full Text]
  16. Shi Y, O'Brien JE Jr, Fard A, Mannion JD, Wang D, and Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 94: 1655–1664, 1996.[Abstract/Free Full Text]
  17. Siow RC, Mallawaarachchi CM, and Weissberg PL. Migration of adventitial myofibroblasts following vascular balloon injury: insights from in vivo gene transfer to rat carotid arteries. Cardiovasc Res 59: 212–221, 2003.[Abstract/Free Full Text]
  18. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP, Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, and Griendling KK. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429–1435, 2002.[Abstract/Free Full Text]
  19. Souza HP, Laurindo FRM, Ziegelstein RC, Berlowitz CO, and Zweier JL. Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control. Am J Physiol Heart Circ Physiol 280: H658–H667, 2001.[Abstract/Free Full Text]
  20. Touyz RM, Chen X, Tabet F, Yao G, He G, Quinn MT, Pagano PJ, and Schiffrin EL. Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II. Circ Res 90: 1205–1213, 2002.[Abstract/Free Full Text]
  21. Wagner AH, Schroeter MR, and Hecker M. 17{beta}-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15: 2121–2130, 2001.[Abstract/Free Full Text]
  22. Wang HD, Xu S, Johns DG, Du Y, Quinn MT, Cayatte AJ, and Cohen RA. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 88: 947–953, 2001.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
HypertensionHome page
M. J. Haurani, M. E. Cifuentes, A. D. Shepard, and P. J. Pagano
Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II-Induced Adventitial Myofibroblast Migration
Hypertension, July 1, 2008; 52(1): 143 - 149.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. B. Friis, K. G. Vorum, and I. H. Lambert
Volume-sensitive NADPH oxidase activity and taurine efflux in NIH3T3 mouse fibroblasts
Am J Physiol Cell Physiol, June 1, 2008; 294(6): C1552 - C1565.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Haurani and P. J. Pagano
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease?
Cardiovasc Res, September 1, 2007; 75(4): 679 - 689.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Zemse, R. H. P. Hilgers, and R. C. Webb
Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. J. Pagano and M. J. Haurani
Vascular Cell Locomotion: Osteopontin, NADPH Oxidase, and Matrix Metalloproteinase-9
Circ. Res., June 23, 2006; 98(12): 1453 - 1455.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Al-Benna, C. A. Hamilton, J. D. McClure, P. N. Rogers, G. A. Berg, I. Ford, C. Delles, and A. F. Dominiczak
Low-Density Lipoprotein Cholesterol Determines Oxidative Stress and Endothelial Dysfunction in Saphenous Veins From Patients With Coronary Artery Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 218 - 223.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M.-S. Zhou, I. H. Schulman, P. J. Pagano, E. A. Jaimes, and L. Raij
Reduced NAD(P)H Oxidase in Low Renin Hypertension: Link Among Angiotensin II, Atherogenesis, and Blood Pressure
Hypertension, January 1, 2006; 47(1): 81 - 86.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. S. Becker, A. Adler, A. Schneeberger, H. Huang, Z. Wang, E. Walsh, A. Koller, and T. H. Hintze
Hyperhomocysteinemia, a Cardiac Metabolic Disease: Role of Nitric Oxide and the p22phox Subunit of NADPH Oxidase
Circulation, April 26, 2005; 111(16): 2112 - 2118.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. Kazama, J. Anrather, P. Zhou, H. Girouard, K. Frys, T. A. Milner, and C. Iadecola
Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase-Derived Radicals
Circ. Res., November 12, 2004; 95(10): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Kalyanaraman and D. D. Gutterman
Prologue: Vascular effects of free radicals
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2253 - H2254.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/H2284    most recent
00459.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chamseddine, A. H.
Right arrow Articles by Miller, F. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chamseddine, A. H.
Right arrow Articles by Miller, F. J., Jr.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2003 by the American Physiological Society.